UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Main results already published
Unique ID issued by UMIN UMIN000021952
Receipt No. R000025308
Scientific Title Study about the effect of minutes and the number of times of dietary intervention to QOL and dietary compliance.
Date of disclosure of the study information 2016/04/18
Last modified on 2017/09/05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Study about the effect of minutes and the number of times of dietary intervention to QOL and dietary compliance.
Acronym Effevtive minutes and the number of times of dietary intervention
Scientific Title Study about the effect of minutes and the number of times of dietary intervention to QOL and dietary compliance.
Scientific Title:Acronym Effevtive minutes and the number of times of dietary intervention
Region
Japan

Condition
Condition Impaired glucose tolerance or Type 2 diabetes mellitus
Classification by specialty
Endocrinology and Metabolism
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 We investigate how long time and how many times we spend on dietary intervention are effective.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Diabetes Therapy-Related QOL (DTR-QOL), compliance of diet therapy, frequency of reducing or increasing of antidiabetic drugs, rate of trial interruption.
Key secondary outcomes Glycoalbumin, HbA1c(NGSP), body weight, blood pressure, urine albumin creatinine ratio (mg/Cr), serum LDL-C, HDL-C, TG, ALT, eGFR.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Educational,Counseling,Training
Type of intervention
Behavior,custom
Interventions/Control_1 In only this group, dietary instruction for 30 minutes at the start, each 20 minute at the 1th and 5th month.

Dietitians do dietary instruction with same materials in both groups, and the total time of instruction is 70 minutes each patient.
In both groups,Daily total energy intake is calculated by multiplying their standard weight by 30 (kcal/kg). Standard macronutrient energy ratio is divided as follows: carbohydrates is 50 % (more than 150 g/day), protein is less than 20 %, and the rest percent is from fats.
And at the start of the study and at the 12th month, we conduct a questionnaire about Diabetes Therapy Related-QOL (DTR-QOL) by iPad or a paper. At the same time, we conduct Food Frequency Questionnaire (FFQ) based on a food diary that patients keep. Then we evaluate compliance of diet therapy.

In both groups, we do not change medication for diabetes in principle, during study. But to prevent hypoglycemia, we reduce a dose in the case that the doctor judge. We recommend patients to increase a dose of antidiabetic drugs if their HbA1c (NGSP) have been greater than 8.0 % for more than 3 months or 7.0 % for more than 6 months. And patients agree to increase a dose of antidiabetic drugs, we will.
Every month during this study, we monitor body weight, BMI, systolic blood pressure, diastolic blood pressure, HbA1c, glycoalbumin. At the 3th, 6th, 9th, 12th month, we monitor serum AST, ALT, gamma-GTP, blood urea nitrogen, Cr, UA, LDL-C, HDL-C, TG, eGFR, urine albumin creatinine ratio (mg/gCr).
Interventions/Control_2 Dietary instruction for 30 minutes at the start, each 5 minute at the 1th, 2th, 3th, 4th, 5th, 6th, 7th, 8th month.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
15 years-old <=
Age-upper limit
85 years-old >
Gender Male and Female
Key inclusion criteria Out-patients with impaired glucose tolerance or Type 2 diabetes mellitus, who have been not treated with dietary instruction by diaetitian for past more than 12 months. In addition, patients who have not had any changes of medication for diabetes, hypertension and dyslipidemia for past more than 3 months.
Key exclusion criteria 1. Type 1 diabetic patients
2. Patients who has renal dysfunction (eGFR is less than 30mL/min/1.73m2)
3. Pregnant women
4. Patients judged by the doctor to be ineligible
Target sample size 120

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Takahiro Tosaki
Organization TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology
Division name Diabetes and Endocrinology
Zip code
Address 2-1007 Motoueda, Tenpaku-ku, Nagoya City 468-0009, Japan
TEL 052-800-2333
Email nrd49075@nifty.com

Public contact
Name of contact person
1st name
Middle name
Last name Takahiro Tosaki
Organization TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology
Division name Diabetes and Endocrinology
Zip code
Address 2-1007 Motoueda, Tenpaku-ku, Nagoya City 468-0009, Japan
TEL 052-800-2333
Homepage URL
Email nrd49075@nifty.com

Sponsor
Institute TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology
Institute
Department

Funding Source
Organization TDE Healthcare Corporation TOSAKI Clinic for Diabetes and Endocrinology
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 医療法人TDE 糖尿病・内分泌内科クリニックTOSAKI (愛知県)

Other administrative information
Date of disclosure of the study information
2016 Year 04 Month 18 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Main results already published
Date of protocol fixation
2016 Year 04 Month 08 Day
Date of IRB
Anticipated trial start date
2016 Year 04 Month 18 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 04 Month 17 Day
Last modified on
2017 Year 09 Month 05 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025308

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.